Compositions, kits, and methods for the modulation of immune responses using galectin-1
US9206427B2 · kind B2 · utility
4Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 17, 2008 |
| Grant date | Dec 8, 2015 |
| Priority date | — |
| Expiry date | Dec 13, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in immune disorders, including Hodgkin lymphoma. Accordingly, the invention relates to compositions, kits, and methods for detecting, characterizing, modulating, preventing, and treating immune disorders, e.g., Hodgkin lymphoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.